Alexis Perkins, 25, tried to get a prescription for PrEP throughout a current go to to her OB-GYN in Atlanta, however her physician didn’t really feel assured prescribing it.
Sam Whitehead/KFF Well being Information
conceal caption
toggle caption
Sam Whitehead/KFF Well being Information
Alexis Perkins, 25, tried to get a prescription for PrEP throughout a current go to to her OB-GYN in Atlanta, however her physician didn’t really feel assured prescribing it.
Sam Whitehead/KFF Well being Information
Alexis Perkins thought her OB-GYN’s workplace in Atlanta can be simply the place to get a prescription for the kind of drug that reduces an individual’s threat of contracting HIV.
However throughout a current go to, the medical assistant who greeted her had not heard of the medicines referred to as preexposure prophylaxis, or PrEP, and he or she appeared uncomfortable discussing it, Perkins says. Her supplier had heard of it however did not really feel assured prescribing it.
“She was at the very least sincere sufficient to say that she was fascinated about it, however she did not actually know that a lot about it,” says Perkins, a 25-year-old nurse, who determined to get on PrEP after collaborating in a sexual well being schooling class and considering extra about her personal threat. She’s nonetheless looking for a supplier to write down her a prescription.
“If I wasn’t actually assured in myself, this might have been a really discouraging expertise,” Perkins says.
PrEP is an important software within the combat in opposition to the ongoing HIV epidemic and, when taken as prescribed, is very efficient at stopping an infection from sexual contact or injection drug use.
However greater than a decade after the first PrEP drug was authorised for the U.S. market, one of many teams that might profit most from the drugs is not taking them: Black ladies, resembling Perkins, whose gender identification align with their intercourse assigned at start.
Lack of expertise
Docs, public well being researchers, and those that present HIV therapy and prevention companies say long-standing, systemic components, resembling stigma and racism, are main limitations to PrEP uptake amongst cisgender Black ladies. Transgender Black ladies face obstacles to PrEP uptake as nicely, particularly discrimination associated to their gender identification.
However many researchers concentrate on cisgender Black ladies, who, they are saying, are sometimes ignored by the well being care system and face obstacles like: noninclusive advertising and marketing resulting in a lack of know-how about who would profit, fewer therapy choices for ladies than for males, and medical professionals cautious to prescribe it. These challenges are much more obvious throughout the South, which has the best charges of latest HIV diagnoses within the nation.
Girls had a few fifth of latest HIV infections in 2021, in line with current knowledge from the Facilities for Illness Management and Prevention. And cisgender Black ladies made up an outsize share.
“If we do not determine how we are able to change the system, we’re simply going to proceed to maintain failing Black ladies,” says Tiara Willie, an assistant professor of psychological well being on the Johns Hopkins Bloomberg Faculty of Public Well being.
The FDA has authorised three medication to be used as PrEP: the capsules Descovy and Truvada, which additionally has a generic model, and the injectable Apretude. Descovy is newer and is available in a smaller pill than Truvada, which might make it extra fascinating. It was authorised for males and transgender ladies who’ve intercourse with males, however wasn’t examined on folks assigned feminine at start.
That call annoyed HIV researchers and advocates, together with Rochelle Walensky, who labored on the Harvard College Middle for AIDS Analysis earlier in her profession, earlier than she led the CDC.
In a 2019 editorial, Walensky and her colleague Robert H. Goldstein criticized this “two-tier system,” through which males can get the remedy understanding it is protected for them and with insurance coverage approval, however ladies cannot.
Gilead Sciences, the corporate that makes Descovy, later introduced it will conduct a trial targeted on the drug’s use amongst cisgender ladies. The corporate stated that research is ongoing, with knowledge anticipated in late 2024. The CDC, for its half, earlier this 12 months introduced an $8 million grant to fund research on methods to extend PrEP uptake amongst Black cisgender ladies.
Black ladies face the identical obstacles as different populations in relation to PrEP, researchers stated, however many achieve this with fewer assets. Current knowledge from the U.S. Census Bureau exhibits Black People disproportionately dwell in poverty and ladies are extra seemingly than males to dwell in poverty.
Frequent physician visits
Taking PrEP requires common testing and physician visits to test for HIV an infection, which might current a “super barrier” to entry due to value and logistics, says Michael Fordham, a program supervisor on the College of Alabama at Birmingham’s 1917 Clinic, the biggest HIV care facility within the state.
“We’re truly seeing PrEP sufferers extra regularly than we see our sufferers residing with HIV which might be steady,” he says.
The CDC up to date its PrEP tips in 2021 to replicate the newest science and drug approvals, however the company has heard complaints from suppliers that they are nonetheless too onerous, says Robyn Neblett Fanfair, performing director of the company’s Division of HIV Prevention. She provides the CDC is “shifting towards” tips which might be extra “well timed and nimble.”
Fanfair says her division can be targeted on decreasing the prices related to taking PrEP, which might be important. Simply beginning on PrEP can value greater than $2,000.
For now, the federal authorities mandates that personal insurance policy cowl PrEP, whilst that rule faces a authorized problem. Nonetheless, in a current research, CDC scientists discovered some 50,000 folks had uncovered PrEP prices in 2018.
“Insurance policies that improve entry to medical insurance, resembling Medicaid enlargement, can enhance entry to PrEP,” the research says. “This can be particularly impactful for the southern US,” the place many states have but to increase the state-federal insurance coverage program for low-income folks below the Inexpensive Care Act.
However paying for PrEP is not the one barrier to entry, particularly within the South.
Risks and stigma
HIV and different sexually transmitted infections can nonetheless be uncomfortable for physicians and nurse practitioners to speak about within the “Bible Belt,” regardless of their prevalence, says Anitra Walker, the vp of operations at Mercy Care, an Atlanta-area well being clinic that will get federal funding.
Social stigma not solely can forestall Black ladies from speaking about PrEP with their associates, neighbors, and docs, however it might seep into their home relationships, says Mauda Monger, an assistant professor on the Faculty of Inhabitants Well being on the College of Mississippi Medical Middle.
“If their companion is the individual offering their housing, their meals, and assets for his or her kids, saying ‘I am on PrEP’ brazenly may very well put her livelihood in jeopardy,” says Monger, noting additional that broaching the topic can put ladies vulnerable to bodily hurt.
Growing PrEP uptake requires increasing entry to good jobs, reasonably priced well being care, and steady housing, Monger says, to permit Black ladies to really feel extra empowered to take management of their well being.
Researchers additionally stated messaging about PrEP and the way it’s marketed wants to vary.
Willie, from Johns Hopkins, performed focus teams in 2019 in Jackson, Mississippi, with Black cisgender ladies, who stated they felt their experiences weren’t mirrored in promoting campaigns for PrEP.
If “it wasn’t simply homosexual males or transgender people who find themselves within the advertisements,” one participant stated, “then it will make all people really feel like … it isn’t only for particular folks.”
Researchers need to “work upstream” to undo these perceptions as soon as they take maintain, says Jessica Gross sales, an affiliate professor at Emory College’s Rollins Faculty of Public Well being.
Alexis Perkins is looking for a supplier to write down her a prescription for PrEP. “If I wasn’t actually assured in myself, this might have been a really discouraging expertise,” she stated.
Sam Whitehead/KFF Well being Information
conceal caption
toggle caption
Sam Whitehead/KFF Well being Information
Alexis Perkins is looking for a supplier to write down her a prescription for PrEP. “If I wasn’t actually assured in myself, this might have been a really discouraging expertise,” she stated.
Sam Whitehead/KFF Well being Information
Gross sales is partnering with Atlanta sexual well being nonprofit SisterLove to coach a small fleet of “influencers” to host casual conversations with group members and research their effectiveness in rising PrEP information, curiosity, and uptake amongst cisgender ladies. Perkins, the nurse who was unable to get a PrEP prescription from her OB-GYN, is a part of the cohort.
SisterLove’s Wholesome Love curriculum, backed by the CDC, provides Black ladies and their social teams the “freedom to carry conversations in another way” than they might with medical suppliers, says the group’s founder, Dázon Dixon Diallo.
Failing to make sure cisgender Black ladies have entry to — and are literally fascinated about taking — PrEP will undermine the combat to convey the HIV epidemic below management, Diallo warns.
There’s “harm that needs to be undone,” she says. “If we’re not centering Black ladies on this epidemic, we’re getting nowhere to the tip.”
KFF Well being Information, previously referred to as Kaiser Well being Information (KHN), is a nationwide newsroom that produces in-depth journalism about well being points and is without doubt one of the core working packages at KFF — the unbiased supply for well being coverage analysis, polling, and journalism.
